Your email has been successfully added to our mailing list.

×
0 0 0.00284900284900289 0.00284900284900289 0.00427350427350423 0.00284900284900289 -0.00142450142450134 0.0142450142450142
Stock impact report

Acorda Has Suffered 2 Setbacks, Both Of Which Can Be Dealt With [Seeking Alpha]

Acorda Therapeutics, Inc. (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
Company Research Source: Seeking Alpha
Summary Acorda Therapeutics receives notice that its inhaled Parkinson's treatment Inbrija has been pushed back to January 5, 2019. Another setback came about when Acorda lost a court battle over 4 patents for the company's multiple sclerosis strengthening drug Ampyra. If Inbrija is ultimately approved by the FDA it could generate up to $800 million in peak sales. In the most recent second-quarter earnings it was noted that Ampyra generated $153.3 million in sales and Acorda stated that it is prepared for upcoming generic versions of the drug. The previous week was a rough one for Acorda Therapeutics ( ACOR ) but I believe that it will recover. The first issue was that the FDA pushed back the PDUFA date for its inhaled therapy for Parkinson's disease by many months. The second problem lies with not being able to uphold patents with its multiple sclerosis drug Ampyra. However, I believe there are certain paths forward. For these reasons, I believe that Acorda Therapeut Show less Read more
Impact Snapshot
Event Time:
ACOR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
ACOR alerts

from News Quantified
Opt-in for
ACOR alerts

from News Quantified